These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 27866520)
1. [Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer]. Zhang Y; Xu Y; Wang M Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):766-772. PubMed ID: 27866520 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02). Lee JY; Qing X; Xiumin W; Yali B; Chi S; Bak SH; Lee HY; Sun JM; Lee SH; Ahn JS; Cho EK; Kim DW; Kim HR; Min YJ; Jung SH; Park K; Mao M; Ahn MJ Oncotarget; 2016 Feb; 7(6):6984-93. PubMed ID: 26755650 [TBL] [Abstract][Full Text] [Related]
3. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples. Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment. Zhu L; Zhang S; Xun Y; Jiang Y; Xia B; Chen X; Wang L; Jiang H; Ma S Pathol Oncol Res; 2018 Oct; 24(4):843-851. PubMed ID: 28868565 [TBL] [Abstract][Full Text] [Related]
5. Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC. Wang Z; Chen R; Wang S; Zhong J; Wu M; Zhao J; Duan J; Zhuo M; An T; Wang Y; Bai H; Wang J PLoS One; 2014; 9(11):e110780. PubMed ID: 25405807 [TBL] [Abstract][Full Text] [Related]
6. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer. He C; Zheng L; Xu Y; Liu M; Li Y; Xu J Clin Chim Acta; 2013 Oct; 425():119-24. PubMed ID: 23886554 [TBL] [Abstract][Full Text] [Related]
7. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells. Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372 [TBL] [Abstract][Full Text] [Related]
8. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value. Alegre E; Fusco JP; Restituto P; Salas-Benito D; Rodríguez-Ruiz ME; Andueza MP; Pajares MJ; Patiño-García A; Pio R; Lozano MD; Gúrpide A; Lopez-Picazo JM; Gil-Bazo I; Perez-Gracia JL; Gonzalez A Tumour Biol; 2016 Oct; 37(10):13687-13694. PubMed ID: 27473086 [TBL] [Abstract][Full Text] [Related]
10. EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs. Liang Z; Cheng Y; Chen Y; Hu Y; Liu WP; Lu Y; Wang J; Wang Y; Wu G; Ying JM; Zhang HL; Zhang XC; Wu YL Cancer Lett; 2017 Sep; 403():186-194. PubMed ID: 28642172 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell-free DNA of non-small cell lung cancer patients. Zaini J; Syahruddin E; Yunus M; Andarini SL; Hudoyo A; Masykura N; Yasril R; Ridwanuloh A; Hidajat H; Nurwidya F; Suharsono S; Utomo ARH Cancer Rep (Hoboken); 2019 Aug; 2(4):e1159. PubMed ID: 32721094 [TBL] [Abstract][Full Text] [Related]
12. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085 [TBL] [Abstract][Full Text] [Related]
13. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study). Takahama T; Sakai K; Takeda M; Azuma K; Hida T; Hirabayashi M; Oguri T; Tanaka H; Ebi N; Sawa T; Bessho A; Tachihara M; Akamatsu H; Bandoh S; Himeji D; Ohira T; Shimokawa M; Nakanishi Y; Nakagawa K; Nishio K Oncotarget; 2016 Sep; 7(36):58492-58499. PubMed ID: 27542267 [TBL] [Abstract][Full Text] [Related]
14. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients. Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405 [TBL] [Abstract][Full Text] [Related]
15. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients. Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441 [TBL] [Abstract][Full Text] [Related]
16. A Rapid and Sensitive Method for Detection of the T790M Mutation of EGFR in Plasma DNA. Kimura H; Nishikawa S; Koba H; Yoneda T; Sone T; Kasahara K Adv Exp Med Biol; 2016; 924():171-174. PubMed ID: 27753039 [TBL] [Abstract][Full Text] [Related]
17. The "COLD-PCR approach" for early and cost-effective detection of tyrosine kinase inhibitor resistance mutations in EGFR-positive non-small cell lung cancer. Mairinger FD; Vollbrecht C; Streubel A; Roth A; Landt O; Walter HF; Kollmeier J; Mairinger T Appl Immunohistochem Mol Morphol; 2014; 22(2):114-8. PubMed ID: 24517913 [TBL] [Abstract][Full Text] [Related]
18. Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. Watanabe M; Kawaguchi T; Isa S; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kakegawa S; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Sakamoto K; Matsumura A; Koh Y Clin Cancer Res; 2015 Aug; 21(15):3552-60. PubMed ID: 25882755 [TBL] [Abstract][Full Text] [Related]
19. Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR. Watanabe M; Kawaguchi T; Isa SI; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kawashima O; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Watanabe K; Matsumura A; Koh Y EBioMedicine; 2017 Jul; 21():86-93. PubMed ID: 28625519 [TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients. Tang C; Zhu L; Zhang L; Tan C; Peng Z; Liu B; Liu W; Hu H; Bai Y; Wang B; Lin L; Liang J; Li X; Guo Y; Liu Y Clin Chim Acta; 2020 Nov; 510():88-96. PubMed ID: 32645388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]